The results revealed that DD-9 can effectively reduce the mRNA expression of β-catenin and its target genes cyclin D1 and LEF1 and inhibit their transcription level, compared to that in the control group in tested cancer cells (Figure 6a,b). Here, LEF1 is linked to cancer.